Cart
sales@molnova.com
Thiazolidinone-Derivatives-1
CAS No. 136272-75-8
Thiazolidinone-Derivatives-1( —— )
Catalog No. M26480 CAS No. 136272-75-8
Thiazolidinone-Derivatives-1 inhibits the secretion of gastric acid and can be used in research on the treatment of gastric and duodenal ulcers.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 25MG | 39 | In Stock |
|
| 50MG | 55 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameThiazolidinone-Derivatives-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionThiazolidinone-Derivatives-1 inhibits the secretion of gastric acid and can be used in research on the treatment of gastric and duodenal ulcers.
-
DescriptionThiazolidinone-Derivatives-1 inhibits the secretion of gastric acid and can be used in research on the treatment of gastric and duodenal ulcers.(In Vitro):Thiazolidinone-Derivatives-1 is an antiulcer agent with a gastric acid secretion-inhibiting effect.
-
In VitroThiazolidinone-Derivatives-1 is extracted from patent WO/1991/008203, compound example 1. Thiazolidinone-Derivatives-1 shows a gastric acid secretion-inhibiting effect and therefore, is useful for the treatment of gastric and duodenal ulcers.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorFAK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number136272-75-8
-
Formula Weight218.27
-
Molecular FormulaC11H10N2OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1SCCN1Cc1ccccc1C#N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Tibesaikosaponin V
Tibesaikosaponin V (TKV) is a triterpene diglycoside, which can be isolated from the methanol extract of the roots of Bupleurum chinense DC.. Tibesaikosaponin V inhibits lipid accumulation and triacylglycerol content occurred without cytotoxicity to adipocytes. Tibesaikosaponin V suppresses the mRNA expression of nuclear transcription factors, such as peroxisome proliferator-activated receptor γ (PPARγ) and CCAAT/enhancer binding protein α (C/EBPα). Tibesaikosaponin V inhibits 3T3-L1 preadipocyte differentiation. Tibesaikosaponin V can be used fro research of obesity and its associated metabolic disorders.
-
KRN-633
KRN-633 is an effective VEGFR inhibitor. The IC50s of KRN-633 for VEGFR1, VEGFR2, and VEGFR3 is 170, 160 and 125 nM, respectively.
-
Bisoxatin
Bisoxatin (LA 271A) is an oral laxative that can be used to study contact laxatives for chronic constipation.
